Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NARU Intelligence is a Spanish health technology company specializing in AI-driven solutions for oncology and other complex diseases. The company's flagship platform, Step Oncology, utilizes real-world evidence and patient-reported outcomes to provide predictive analytics that improve clinical decision-making and patient monitoring. By integrating data from clinical records and patient-generated inputs, NARU helps healthcare providers and pharmaceutical companies optimize treatments and accelerate drug development. Their technology focuses on reducing complications and enhancing the quality of life for patients undergoing intensive treatments. The platform is designed to provide personalized follow-up and early detection of adverse events in a clinical setting.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NARU Intelligence Solutions.